MEA透析器再処理装置市場 - 2030年までの産業動向と予測MEA Dialyzer Reprocessing Machines Market - Industry Trends and Forecast to 2030 中東・アフリカのダイアライザー再処理機市場は、2022年の43億6,379万米ドルから2030年には51億1,156万米ドルに達し、2023年から2033年の予測期間中に年平均成長率2.0%で成長すると予測される。 市場区分 中... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー中東・アフリカのダイアライザー再処理機市場は、2022年の43億6,379万米ドルから2030年には51億1,156万米ドルに達し、2023年から2033年の予測期間中に年平均成長率2.0%で成長すると予測される。市場区分 中東・アフリカ透析器再処理装置市場:タイプ別(自動、半自動)、モダリティ別(ベンチトップ、スタンドアロン)、ステーションタイプ別(シングルステーション、デュアルステーション)、エンドユーザー別(病院、透析センター、ホームユース)、国別(サウジアラビア、エジプト、イスラエル、中東・アフリカその他)-産業動向と2030年までの予測 中東・アフリカ地域の透析器再処理装置市場動向の概要 推進要因 - 末期腎不全(ESRD)の増加 抑制要因 - 厳しい承認規制 機会 - 技術の進歩 市場プレイヤー 中東・アフリカのダイアライザー再処理機市場で事業を展開している主な市場プレイヤーをいくつか紹介する: - アドビンヘルスケア - ゲリーファルコンヘルスケア社 - ウェスレー・バイオテック - P.K.サイエンティフィック&ケミカルズ - クリニバヘルスケア - MEDIVATORS社(STERIS社子会社)アトランティックバイオメディカル社 - ザウバーン - その他 目次TABLE OF CONTENTS1 INTRODUCTION 25 1.1 OBJECTIVES OF THE STUDY 25 1.2 MARKET DEFINITION 25 1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET 25 1.4 LIMITATIONS 26 1.5 MARKETS COVERED 27 2 MARKET SEGMENTATION 29 2.1 MARKETS COVERED 29 2.2 GEOGRAPHICAL SCOPE 30 2.3 YEARS CONSIDERED FOR THE STUDY 31 2.4 CURRENCY AND PRICING 31 2.5 DBMR TRIPOD DATA VALIDATION MODEL 32 2.6 MULTIVARIATE MODELLING 35 2.7 TYPE LIFELINE CURVE 35 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36 2.9 DBMR MARKET POSITION GRID 37 2.10 MARKET END USER COVERAGE GRID 38 2.11 VENDOR SHARE ANALYSIS 39 2.12 SECONDARY SOURCES 40 2.13 ASSUMPTIONS 40 3 EXECUTIVE SUMMARY 41 4 PREMIUM INSIGHTS 44 4.1 PESTEL ANALYSIS 45 4.2 PORTER’S FIVE FORCES MODEL 46 4.3 STRATEGIC INITIATIVES 47 5 MIDDLE EAST & AFRICA DIALYZER PROCESSING MACHINES MARKET, REGULATIONS 48 6 MARKET OVERVIEW 49 6.1 DRIVERS 51 6.1.1 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 51 6.1.2 RISING DEMAND FOR HOME-BASED DIALYSIS PROCEDURES 51 6.1.3 COST-EFFECTIVENESS AND EFFICIENCY 52 6.2 RESTRAINTS 53 6.2.1 STRINGENT REGULATIONS FOR APPROVAL 53 6.2.2 POSSIBLE RISK OF INFECTIONS 53 6.3 OPPORTUNITIES 54 6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS 54 6.3.2 INCREASING FOCUS ON INFECTION CONTROL 55 6.4 CHALLENGES 55 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE DIALYZER REPROCESSING MACHINES 55 6.4.2 LACK OF STANDARDIZATION 56 7 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY TYPE 57 7.1 OVERVIEW 58 7.2 SEMI-AUTOMATIC 61 7.3 AUTOMATIC 62 8 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY MODALITY 63 8.1 OVERVIEW 64 8.2 BENCHTOP 67 8.2.1 SEMI-AUTOMATIC 68 8.2.2 AUTOMATIC 68 8.3 STANDALONE 68 8.3.1 SEMI-AUTOMATIC 69 8.3.2 AUTOMATIC 69 9 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY STATION TYPE 70 9.1 OVERVIEW 71 9.2 DUAL STATION 74 9.3 SINGLE STATION 75 10 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY END USER 76 10.1 OVERVIEW 77 10.2 DIALYSIS CENTERS 80 10.3 HOSPITAL 81 10.4 HOME USE 82 11 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY REGION 83 11.1 MIDDLE EAST AND AFRICA 84 11.1.1 SAUDI ARABIA 91 11.1.2 EGYPT 93 11.1.3 ISRAEL 95 11.1.4 REST OF MIDDLE EAST AND AFRICA 97 12 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET: COMPANY LANDSCAPE 98 12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 98 13 SWOT ANALYSIS 99 14 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET 100 14.1 MEDIVATORS INC. (SUBSIDIARY OF STERIS) 100 14.1.1 COMPANY SNAPSHOT 100 14.1.2 REVENUE ANALYSIS 100 14.1.3 COMPANY SHARE ANALYSIS 101 14.1.4 PRODUCT PORTFOLIO 101 14.1.5 RECENT DEVELOPMENTS 101 14.2 HEMANT SURGICAL INDUSTRIES LTD. 102 14.2.1 COMPANY SNAPSHOT 102 14.2.2 REVENUE ANALYSIS 102 14.2.3 COMPANY SHARE ANALYSIS 103 14.2.4 PRODUCT PORTFOLIO 103 14.2.5 RECENT DEVELOPMENTS 103 14.3 SAUBERN 104 14.3.1 COMPANY SNAPSHOT 104 14.3.2 COMPANY SHARE ANALYSIS 104 14.3.3 PRODUCT PORTFOLIO 105 14.3.4 RECENT DEVELOPMENTS 105 14.4 P.K. SCIENTIFIC & CHEMICALS 106 14.4.1 COMPANY SNAPSHOT 106 14.4.2 PRODUCT PORTFOLIO 106 14.4.3 RECENT DEVELOPMENT 106 14.5 LABSMED. 107 14.5.1 COMPANY SNAPSHOT 107 14.5.2 COMPANY SHARE ANALYSIS 107 14.5.3 PRODUCT PORTFOLIO 108 14.5.4 RECENT DEVELOPMENTS 108 14.6 ATLANTIC BIOMEDICAL 109 14.6.1 COMPANY SNAPSHOT 109 14.6.2 COMAPYN SHARE ANALYSIS 109 14.6.3 PRODUCT PORTFOLIO 110 14.6.4 RECENT DEVELOPMENT 110 14.7 ADVIN HEALTH CARE 111 14.7.1 COMPANY SNAPSHOT 111 14.7.2 PRODUCT PORTFOLIO 111 14.7.3 RECENT DEVELOPMENTS 111 14.8 ANJUE MEDICAL EQUIPMENT CO., LTD. 112 14.8.1 COMPANY SNAPSHOT 112 14.8.2 PRODUCT PORTFOLIO 112 14.8.3 RECENT DEVELOPMENT 112 14.9 CLINIVA HEALTHCARE 113 14.9.1 COMPANY SNAPSHOT 113 14.9.2 PRODUCT PORTFOLIO 113 14.9.3 RECENT DEVELOPMENT 113 14.10 GERYFALCON HEALTHCARE PVT. LTD. 114 14.10.1 COMPANY SNAPSHOT 114 14.10.2 PRODUCT PORTFOLIO 114 14.10.3 RECENT DEVELOPMENT 114 14.11 NANOTECH 115 14.11.1 COMPANY SNAPSHOT 115 14.11.2 PRODUCT PORTFOLIO 115 14.11.3 RECENT DEVELOPMENTS 115 14.12 WESLEY BIOTECH 116 14.12.1 COMPANY SNAPSHOT 116 14.12.2 PRODUCT PORTFOLIO 116 14.12.3 RECENT DEVELOPMENT 116 15 QUESTIONNAIRE 117 16 RELATED REPORTS 120
SummaryMiddle East & Africa dialyzer reprocessing machines market is expected to reach USD 5,111.56 million by 2030 from USD 4,363.79 million in 2022, growing at a CAGR of 2.0% during the forecast period of 2023 to 2033. Table of ContentsTABLE OF CONTENTS1 INTRODUCTION 25 1.1 OBJECTIVES OF THE STUDY 25 1.2 MARKET DEFINITION 25 1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET 25 1.4 LIMITATIONS 26 1.5 MARKETS COVERED 27 2 MARKET SEGMENTATION 29 2.1 MARKETS COVERED 29 2.2 GEOGRAPHICAL SCOPE 30 2.3 YEARS CONSIDERED FOR THE STUDY 31 2.4 CURRENCY AND PRICING 31 2.5 DBMR TRIPOD DATA VALIDATION MODEL 32 2.6 MULTIVARIATE MODELLING 35 2.7 TYPE LIFELINE CURVE 35 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36 2.9 DBMR MARKET POSITION GRID 37 2.10 MARKET END USER COVERAGE GRID 38 2.11 VENDOR SHARE ANALYSIS 39 2.12 SECONDARY SOURCES 40 2.13 ASSUMPTIONS 40 3 EXECUTIVE SUMMARY 41 4 PREMIUM INSIGHTS 44 4.1 PESTEL ANALYSIS 45 4.2 PORTER’S FIVE FORCES MODEL 46 4.3 STRATEGIC INITIATIVES 47 5 MIDDLE EAST & AFRICA DIALYZER PROCESSING MACHINES MARKET, REGULATIONS 48 6 MARKET OVERVIEW 49 6.1 DRIVERS 51 6.1.1 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 51 6.1.2 RISING DEMAND FOR HOME-BASED DIALYSIS PROCEDURES 51 6.1.3 COST-EFFECTIVENESS AND EFFICIENCY 52 6.2 RESTRAINTS 53 6.2.1 STRINGENT REGULATIONS FOR APPROVAL 53 6.2.2 POSSIBLE RISK OF INFECTIONS 53 6.3 OPPORTUNITIES 54 6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS 54 6.3.2 INCREASING FOCUS ON INFECTION CONTROL 55 6.4 CHALLENGES 55 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE DIALYZER REPROCESSING MACHINES 55 6.4.2 LACK OF STANDARDIZATION 56 7 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY TYPE 57 7.1 OVERVIEW 58 7.2 SEMI-AUTOMATIC 61 7.3 AUTOMATIC 62 8 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY MODALITY 63 8.1 OVERVIEW 64 8.2 BENCHTOP 67 8.2.1 SEMI-AUTOMATIC 68 8.2.2 AUTOMATIC 68 8.3 STANDALONE 68 8.3.1 SEMI-AUTOMATIC 69 8.3.2 AUTOMATIC 69 9 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY STATION TYPE 70 9.1 OVERVIEW 71 9.2 DUAL STATION 74 9.3 SINGLE STATION 75 10 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY END USER 76 10.1 OVERVIEW 77 10.2 DIALYSIS CENTERS 80 10.3 HOSPITAL 81 10.4 HOME USE 82 11 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET, BY REGION 83 11.1 MIDDLE EAST AND AFRICA 84 11.1.1 SAUDI ARABIA 91 11.1.2 EGYPT 93 11.1.3 ISRAEL 95 11.1.4 REST OF MIDDLE EAST AND AFRICA 97 12 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET: COMPANY LANDSCAPE 98 12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 98 13 SWOT ANALYSIS 99 14 MIDDLE EAST & AFRICA DIALYZER REPROCESSING MACHINES MARKET 100 14.1 MEDIVATORS INC. (SUBSIDIARY OF STERIS) 100 14.1.1 COMPANY SNAPSHOT 100 14.1.2 REVENUE ANALYSIS 100 14.1.3 COMPANY SHARE ANALYSIS 101 14.1.4 PRODUCT PORTFOLIO 101 14.1.5 RECENT DEVELOPMENTS 101 14.2 HEMANT SURGICAL INDUSTRIES LTD. 102 14.2.1 COMPANY SNAPSHOT 102 14.2.2 REVENUE ANALYSIS 102 14.2.3 COMPANY SHARE ANALYSIS 103 14.2.4 PRODUCT PORTFOLIO 103 14.2.5 RECENT DEVELOPMENTS 103 14.3 SAUBERN 104 14.3.1 COMPANY SNAPSHOT 104 14.3.2 COMPANY SHARE ANALYSIS 104 14.3.3 PRODUCT PORTFOLIO 105 14.3.4 RECENT DEVELOPMENTS 105 14.4 P.K. SCIENTIFIC & CHEMICALS 106 14.4.1 COMPANY SNAPSHOT 106 14.4.2 PRODUCT PORTFOLIO 106 14.4.3 RECENT DEVELOPMENT 106 14.5 LABSMED. 107 14.5.1 COMPANY SNAPSHOT 107 14.5.2 COMPANY SHARE ANALYSIS 107 14.5.3 PRODUCT PORTFOLIO 108 14.5.4 RECENT DEVELOPMENTS 108 14.6 ATLANTIC BIOMEDICAL 109 14.6.1 COMPANY SNAPSHOT 109 14.6.2 COMAPYN SHARE ANALYSIS 109 14.6.3 PRODUCT PORTFOLIO 110 14.6.4 RECENT DEVELOPMENT 110 14.7 ADVIN HEALTH CARE 111 14.7.1 COMPANY SNAPSHOT 111 14.7.2 PRODUCT PORTFOLIO 111 14.7.3 RECENT DEVELOPMENTS 111 14.8 ANJUE MEDICAL EQUIPMENT CO., LTD. 112 14.8.1 COMPANY SNAPSHOT 112 14.8.2 PRODUCT PORTFOLIO 112 14.8.3 RECENT DEVELOPMENT 112 14.9 CLINIVA HEALTHCARE 113 14.9.1 COMPANY SNAPSHOT 113 14.9.2 PRODUCT PORTFOLIO 113 14.9.3 RECENT DEVELOPMENT 113 14.10 GERYFALCON HEALTHCARE PVT. LTD. 114 14.10.1 COMPANY SNAPSHOT 114 14.10.2 PRODUCT PORTFOLIO 114 14.10.3 RECENT DEVELOPMENT 114 14.11 NANOTECH 115 14.11.1 COMPANY SNAPSHOT 115 14.11.2 PRODUCT PORTFOLIO 115 14.11.3 RECENT DEVELOPMENTS 115 14.12 WESLEY BIOTECH 116 14.12.1 COMPANY SNAPSHOT 116 14.12.2 PRODUCT PORTFOLIO 116 14.12.3 RECENT DEVELOPMENT 116 15 QUESTIONNAIRE 117 16 RELATED REPORTS 120
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Data Bridge Market Research社の医療デバイス分野での最新刊レポート
本レポートと同じKEY WORD(mea)の最新刊レポートよくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|